■Company Name

LocomoGene, Inc.

■Company Address

Leading Venture Plaza-2 (Room No.400)
75-1 Ono-cho, Tsurumi-ku, Yokohama,
Kanagawa 230-0046, Japan
Phone:+81-45-508-6511
Facsimile:+81-45-508-6541

■Homepage Address

http://www.locomogene.com/english/index.html

■Email Contact

locomo@locomogene.com

■President

Toshihiro Nakajima, M.D., Ph.D.

■Principal Area of Business

LocomoGene aims at developing novel medicines based on genome research.

■Principal Products/Business Activities

l        Synoviolin, discovered through the analysis of synovial tissue with rheumatoid arthritis. LocomoGene has been using its own unique know-how to simultaneously render genomic information leading to drug discovery and is exploiting the avenue to a curative treatment of rheumatoid arthritis.

■Business Goals

Currently LocomoGene is searching for associations with diseases generating from the bindings of more than 130 substrate candidates to Synoviolin. We look to "Neurotonin" to be the next drug discovery target and are now charting a course towards further drug discoveries.

■Year of Establishment

May 14, 2001

■Company Photo